Psychosis before first onset

Medical Journal of Australia

Volumn 196, Issue 9, 2012, Pages 557-

  Castle, David J ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; POLYUNSATURATED FATTY ACID;

COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL (TOPIC); COUNSELING; DISEASE COURSE; FAMILY HISTORY; HUMAN; NOTE; PATIENT MONITORING; PREDICTIVE VALUE; PSYCHOSIS; PSYCHOTHERAPY; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SOCIAL STIGMA; SYMPTOM; ULTRA HIGH RISK CRITERIA; ARTICLE; DECISION SUPPORT SYSTEM;

DECISION SUPPORT TECHNIQUES; HUMANS; PSYCHOTIC DISORDERS; RISK ASSESSMENT; RISK FACTORS; SCHIZOPHRENIA;

EID: 84861607328     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja12.10669     Document Type: Note

References (5)

1. Yung AR, McGorry PD, McFarlane C, et al. Monitoring and care of young people at incipient risk of psychosis. Schizoph Bull 1996; 22: 283-303.
2. Fusar-Poli P, Bonoldi I, Yung AR, et al. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry 2012; 69: 220-229.
3. Carr V. Time to move on? Commentary on the early intervention in psychosis debate. ANZ J Psychiatry 2012; 46: 384-386.
4. Morrison AP, French P, Stewart SLK, et al. Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial. BMJ 2012; 344: e2233. doi: 10.1136/bmj.e2233.
5. Bechdolf A, Wagner M, Ruhrmann S, et al. Preventing progression to firstepisode psychosis in early initial prodromal states. Br J Psychiatry 2012; 200: 22-29.